dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Rodríguez-Bernal, Clara L. |
dc.contributor.author | Sanchez-Saez, Francisco |
dc.contributor.author | Bejarano-Quisoboni, Daniel |
dc.contributor.author | Riera Arnau, Judit |
dc.contributor.author | Sanfélix-Gimeno, Gabriel |
dc.contributor.author | Hurtado, Isabel |
dc.date.accessioned | 2022-06-20T08:03:22Z |
dc.date.available | 2022-06-20T08:03:22Z |
dc.date.issued | 2021-12-13 |
dc.identifier.citation | Rodríguez-Bernal CL, Sanchez-Saez F, Bejarano-Quisoboni D, Riera-Arnau J, Sanfélix-Gimeno G, Hurtado I. Real-World Management and Clinical Outcomes of Stroke Survivors With Atrial Fibrillation: A Population-Based Cohort in Spain. Front Pharmacol. 2021 Dec 13;12:789783. |
dc.identifier.issn | 1663-9812 |
dc.identifier.uri | https://hdl.handle.net/11351/7713 |
dc.description | Antiplaquetàries; Fibril·lació auricular; Estratègies de tractament |
dc.description.sponsorship | CR-B was funded at the start of this work by the Instituto de Salud Carlos III, Spanish Ministry of Health, co-financed by the European Regional Development Fund (grant number RD16/0001/0011) and currently through a competitive grant (Sara Borrell CD19/00137). FS-S was funded by the Instituto de Salud Carlos III, Spanish Ministry of Health through the REDISSEC network (grant number RD16/0001/0011). The views presented here are those of the authors and not necessarily those of the FISABIO Foundation, the Valencia Ministry of Health or the study sponsors. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Pharmacology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Malalties cerebrovasculars - Prevenció |
dc.subject | Fibril·lació auricular |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Stroke |
dc.subject.mesh | Atrial Fibrillation |
dc.subject.mesh | Treatment Outcome |
dc.title | Real-World Management and Clinical Outcomes of Stroke Survivors With Atrial Fibrillation: A Population-Based Cohort in Spain |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fphar.2021.789783 |
dc.subject.decs | accidente cerebrovascular |
dc.subject.decs | fibrilación atrial |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.3389/fphar.2021.789783 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rodríguez-Bernal CL, Sanchez-Saez F, Sanfélix-Gimeno G, Hurtado I] Health Services Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), Valencia, Spain. Research Network on Health Services in Chronic Diseases, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Valencia, Spain. [Bejarano-Quisoboni D] Health Services Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), Valencia, Spain. [Riera-Arnau J] Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34966283 |
dc.identifier.wos | 000735961600001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |